107 related articles for article (PubMed ID: 16830956)
21. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
22. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma.
Streubel B; Vinatzer U; Lamprecht A; Raderer M; Chott A
Leukemia; 2005 Apr; 19(4):652-8. PubMed ID: 15703784
[TBL] [Abstract][Full Text] [Related]
23. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.
Fang JM; Finn WG; Hussong JW; Goolsby CL; Cubbon AR; Variakojis D
Mod Pathol; 1999 Mar; 12(3):295-300. PubMed ID: 10102615
[TBL] [Abstract][Full Text] [Related]
24. Programmed death-1 expression in cutaneous B-cell lymphoma.
Çetinözman F; Koens L; Jansen PM; Willemze R
J Cutan Pathol; 2014 Jan; 41(1):14-21. PubMed ID: 24151955
[TBL] [Abstract][Full Text] [Related]
25. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.
Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S
J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486
[TBL] [Abstract][Full Text] [Related]
26. Clonality of cutaneous B-cell infiltrates determined by microdissection and immunoglobulin gene rearrangement.
Signoretti S; Murphy M; Puddu P; DeCoteau JF; Faraggiana T; Kadin ME; Loda M
Diagn Mol Pathol; 1999 Dec; 8(4):176-82. PubMed ID: 10617273
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous Borreliosis With a T-Cell-Rich Infiltrate and Simultaneous Involvement by B-Cell Chronic Lymphocytic Leukemia With t(14;18)(q32;q21).
Kempf W; Kazakov DV; Hübscher E; Tinguely M
Am J Dermatopathol; 2015 Sep; 37(9):715-8. PubMed ID: 25171429
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous T-cell-rich B-cell lymphoma: clinically distinct from its nodal counterpart?
Li S; Griffin CA; Mann RB; Borowitz MJ
Mod Pathol; 2001 Jan; 14(1):10-3. PubMed ID: 11211304
[TBL] [Abstract][Full Text] [Related]
30. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
31. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
[TBL] [Abstract][Full Text] [Related]
32. Absence of MALT1 translocations in primary cutaneous marginal zone B-cell lymphoma.
Espinet B; Gallardo F; Pujol RM; Estrach T; Servitje O; Solé F
Haematologica; 2004 Sep; 89(9):ELT14. PubMed ID: 15377491
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.
Geyer JT; Ferry JA; Longtine JA; Flotte TJ; Harris NL; Zukerberg LR
Am J Clin Pathol; 2010 Jan; 133(1):59-69. PubMed ID: 20023259
[TBL] [Abstract][Full Text] [Related]
34. Composite lymphoma of mycosis fungoides and cutaneous small B-cell lymphoma in a 73-year-old male patient.
Whitling NA; Shanesmith RP; Jacob L; McBurney E; Sebastian S; Wang E; Wang AR
Hum Pathol; 2013 Apr; 44(4):670-5. PubMed ID: 23313307
[TBL] [Abstract][Full Text] [Related]
35. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas.
Hallermann C; Kaune KM; Gesk S; Martin-Subero JI; Gunawan B; Griesinger F; Vermeer MH; Santucci M; Pimpinelli N; Willemze R; Siebert R; Neumann C
J Invest Dermatol; 2004 Jul; 123(1):213-9. PubMed ID: 15191563
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous B-cell lymphoma (marginal zone) with prominent T-cell component and aberrant dual (T and B) genotype; diagnostic usefulness of laser-capture microdissection.
Gallardo F; Pujol RM; Bellosillo B; Ferrer D; García M; Barranco C; Planagumà M; Serrano S
Br J Dermatol; 2006 Jan; 154(1):162-6. PubMed ID: 16403112
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential.
Nihal M; Mikkola D; Horvath N; Gilliam AC; Stevens SR; Spiro TP; Cooper KD; Wood GS
Hum Pathol; 2003 Jun; 34(6):617-22. PubMed ID: 12827617
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
[TBL] [Abstract][Full Text] [Related]
39. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications.
Kutzner H; Kerl H; Pfaltz MC; Kempf W
Am J Surg Pathol; 2009 Sep; 33(9):1307-13. PubMed ID: 19718787
[TBL] [Abstract][Full Text] [Related]
40. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
